In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • A Novel VEGF-responsive lincRNA Regulates Angiogenesis in Glioblastoma

    Final Number:

    Sunit Das MD PhD

    Study Design:
    Laboratory Investigation

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2013 Annual Meeting

    Introduction: Large intergenic RNAs (lincRNA) are involved in numerous cellular processes, including those relevant to normal development and cancer progression. We speculated that differential lincRNAs expression would be important to fate specification in endothelial cells.

    Methods: To detect lincRNAs that are functionally important in the process of human angiogenesis, a custom microarray was used to profile long non-coding transcripts in human vascular endothelium in two-dimensional versus three-dimensional pro-angiogenic cultures, with or without VEGF-A165.

    Results: We identified a VEGF-A-responsive lincRNA near the VEGFR1 gene, which we termed LiVE1 (lincRNA-VEGFR1). Through knockdown and over-expression studies, we found LiVE1 to exert transcriptional control over multiple genes involved in the angiogenesis signaling cascade, including VEGFR1, VEGFR2, and Flt1, and to direct vascular maturation in vitro. Given its significance to endothelial cell differentiation and maturation, we postulated that LiVE1 could have a role in neoplastic angiogenesis in glioblastoma. Indeed, we found that LiVE1 is highly expressed in glioblastoma and is enriched in the CD133+ glioma stem cell and CD133+CD144+ endothelial progenitor populations. In vivo knockdown of the LIVE1 using nanoparticles-based RNAi decreased microvascular density and tumour volume in a heterotopic glioblastoma xenograft model, and resulted in local tumor control in an orthotopic xenograft model.

    Conclusions: Our studies affirm that lincRNAs are important cellular effector molecules that have significant therapeutic potential and merit attention as targets for pharmaceutical innovation. Knockdown of LiVE1 may be an effective means to target vascular neogenesis in glioblastoma.

    Patient Care: LiVE1 may be a therapeutic target in glioblastoma.

    Learning Objectives: By the conclusion of this session, participants should 1) Understand the identity of long non-coding RNAs and their relevance to cell biology; 2) Understand the role of LiVE1 in vascular maturation in glioblastoma.

    References: 1. Ulitsky, I., Shkumatava, A., Jan, C.H., Sive, H. & Bartel, D.P. Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell 147, 1537-1550 (2011). 2. Guttman, M., et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477, 295-300 (2011). 3. Gong, C. & Maquat, L.E. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3' UTRs via Alu elements. Nature 470, 284-288 (2011). 4. Cesana, M., et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147, 358-369 (2011). 5. Orom, U.A., et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 143, 46-58 (2010). 6. Kino, T., Hurt, D.E., Ichijo, T., Nader, N. & Chrousos, G.P. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal 3, ra8 (2010). 7. Tripathi, V., et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 39, 925-938 (2010). 8. Roberts, K.A., Abraira, V.E., Tucker, A.F., Goodrich, L.V. & Andrews, N.C. Mutation of rubie, a novel long non-coding RNA located upstream of bmp4, causes vestibular malformation in mice. PLoS One 7, e29495 (2012). 9. Yang, C., Li, X., Wang, Y., Zhao, L. & Chen, W. Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene 496, 8-16 (2012). 10. Zhang, W., et al. Variants on chromosome 9p21.3 correlated with ANRIL expression contribute to stroke risk and recurrence in a large prospective stroke population. Stroke 43, 14-21 (2012). 11. Gupta, R.A., et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076 (2010). 12. Kotake, Y., et al. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 30, 1956-1962 (2011). 13. Lai, M.C., et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol (2011). 14. Prensner, J.R., et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol 29, 742-749 (2011). 15. Ren, S., et al. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res (2012). 16. Pandey, R.R., et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell 32, 232-246 (2008). 17. Wang, K.C., et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472, 120-124 (2011). 18. Li, K., et al. A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo. Blood 115, 133-139 (2010). 19. Singh, S.K., et al. Identification of human brain tumour initiating cells. Nature 432, 396-401 (2004). 20. Ricci-Vitiani, L., et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468, 824-828 (2010). 21. Wang, R., et al. Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468, 829-833 (2010).

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy